Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazuhito Suzuki
Institution:
Jikei University School of Medicine
Observed institution:
Jikei University School of Medicine
ORCID:
0000-0002-0300-378X
Observed ORCID:
0000-0002-0300-378X
OpenAlex ID:
A5101390358
Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma
2026
·
Kazuhito Suzuki
, Tadahiro Gunji
, et al.
·
Japanese Journal of Clinical Oncology
·
2
Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma
2026
·
Keita Ishii
, Kazuhito Suzuki
, et al.
·
International Journal of Hematology
·
2
Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108
2026
·
Suein Choi
, Ja Min Byun
, et al.
·
Blood Cancer Journal
PDF
Hematologic response and kidney outcomes of monoclonal gammopathy of renal significance excluding AL amyloidosis: a report of six cases
2026
·
Hiroki Nobayashi
, Kotaro Haruhara
, et al.
·
BMC Nephrology
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias
2026
·
Kazuhito Suzuki
·
International Journal of Hematology
Belantamab mafodotin, pomalidomide, and dexamethasone in Japanese patients with RRMM in the phase 3 DREAMM-8 trial
2026
·
Kazutaka Sunami
, Hiroshi Handa
, et al.
·
International Journal of Hematology
PDF
[Treatment strategies for newly diagnosed multiple myeloma and the clinical significance of minimal residual disease negativity].
2026
·
Kazuhito Suzuki
·
PubMed
Show more works
View as search
Works count:
7
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type